
Researchers at the Indian Institute of Technology Kanpur have discovered a pathway through which immune cells in the pancreas can suppress insulin secretion within minutes, potentially opening new avenues for diabetes research.

The study, led by Simran Singh and Ashish Kumar under the supervision of Dr Sai Prasad Pydi, found that macrophages directly interact with beta cells to reduce insulin release. It was published in the Journal of Clinical Investigation.
The team confirmed the pathway is active in human pancreatic tissue, making it a potential drug target for protecting insulin production in people with obesity and type 2 diabetes. The trigger is a receptor called GPR18 on macrophages.
Both outlets report the study's findings in a neutral, wire-style manner, leading with the discovery and attributing the details to the researchers and the institute. Neither adds commentary on policy or broader implications, and each omits any potential caveats or criticism. The Economic Times notes the Journal of Clinical Investigation publication, while Deccan Chronicle places the research in Mumbai. The coverage is essentially uniform, mirroring the press statement's framing without independent analysis.
The balanced reading is that the study is presented as a promising scientific advance, with both sources emphasising the novelty of the rapid signal exchange and the validation in human tissue. Neither outlet questions the findings or the stated potential for drug development, which may overstate the translational readiness given the study does not offer a treatment.
Coverage: 2 sources, 2 neutral
Sources (2): deccanchronicle.com (neutral report), economictimes.indiatimes.com (neutral report)
This brief was synthesised by AI from the 2 sources linked above, so one read covers every framing they carry. Methodology and corrections.